Inhibikase Therapeutics, Inc.
SEC Filing List
IKT CIK: 0001750149
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | Toppan Merrill/FA | 08/14/2026 | |||
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/14/2026 | |||
| SCHEDULE 13G/A | 08/13/2026 | ||||
| 10-Q | Quarterly report pursuant to Section 13 ... | Inhibikase Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/11/2026 | |
| 8-K | Current report filing | Inhibikase Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/11/2026 | |
| S-8 | Initial registration statement for secur... | Inhibikase Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/11/2026 | |
| 4 | Statement of changes in beneficial owner... | Berman Dennis N | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 07/31/2026 | |
| SCHEDULE 13G/A | 07/31/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Cooley LLP /fa | 07/31/2026 | ||
| 8-K | Current report filing | Inhibikase Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 07/29/2026 | |
| No record found. | |||||
| Load More | |||||
